These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 14620391)

  • 1. Systemic antifungal therapy: new options, new challenges.
    Wong-Beringer A; Kriengkauykiat J
    Pharmacotherapy; 2003 Nov; 23(11):1441-62. PubMed ID: 14620391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical indications for newer antifungal agents.
    Naeger-Murphy N; Pile JC
    J Hosp Med; 2009 Feb; 4(2):102-11. PubMed ID: 19219926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases].
    Karthaus M; Böhme A
    Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspofungin.
    Parakh A; Dubey AP; Samanta D
    Indian Pediatr; 2008 Nov; 45(11):905-10. PubMed ID: 19029563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for managing systemic fungal infection and the place of itraconazole.
    Potter M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i49-i54. PubMed ID: 16120634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspofungin: first approved agent in a new class of antifungals.
    Johnson MD; Perfect JR
    Expert Opin Pharmacother; 2003 May; 4(5):807-23. PubMed ID: 12740003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
    Keating G; Figgitt D
    Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of itraconazole in haematology/oncology.
    Pandya NA; Atra AA; Riley U; Pinkerton CR
    Arch Dis Child; 2003 Mar; 88(3):258-60. PubMed ID: 12598396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic fungal infections in patients with hematologic malignancies: indications and limitations of the antifungal armamentarium.
    Böhme A; Karthaus M
    Chemotherapy; 1999; 45(5):315-24. PubMed ID: 10473919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric antifungal therapy in patients with febrile neutropenia.
    Ferrara JJ; MacDougall C; Gallagher JC
    Pharmacotherapy; 2011 Apr; 31(4):369-85. PubMed ID: 21449626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspofungin acetate for treatment of invasive fungal infections.
    Pacetti SA; Gelone SP
    Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
    Agarwal MB; Rathi SA; Ratho N; Subramanian R
    J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer systemic antifungal agents : pharmacokinetics, safety and efficacy.
    Boucher HW; Groll AH; Chiou CC; Walsh TJ
    Drugs; 2004; 64(18):1997-2020. PubMed ID: 15341494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections.
    Groll AH; Walsh TJ
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1545-58. PubMed ID: 11772269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
    van 't Wout JW; Kuijper EJ; Verweij PE; Kullberg BJ
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1679-84. PubMed ID: 15453120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing strategies for the management of invasive fungal infections.
    Rapp RP
    Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole versus amphotericin B in cancer patients with neutropenia.
    Jørgensen KJ; Gøtzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of invasive mycoses in hematology patients: current approaches.
    Perfect JR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):5-14. PubMed ID: 15651177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
    Colombo GL; Morlotti L; Serra G
    Recenti Prog Med; 2005 Sep; 96(9):416-23. PubMed ID: 16229321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.